Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer

Fendler, A; Shepherd, STC; Au, L; Wu, M; Harvey, R; Schmitt, AM; Tippu, Z; Shum, B; Farag, S; Rogiers, A; Carlyle, E; Edmonds, K; Del Rosario, L; Lingard, K; Mangwende, M; Holt, L; Ahmod, H; Korteweg, J; Foley, T; Barber, T; Emslie-Henry, A; Caulfield-Lynch, N; Byrne, F; Deng, DQ; Kjaer, S; Song, OR; Queval, C; Kavanagh, C; Wall, EC; Carr, EJ; Caidan, S; Gavrielides, M; MacRae, JI; Kelly, G; Peat, K; Kelly, D; Murra, A; Kelly, K; O'Flaherty, M; Shea, RL; Gardner, G; Murray, D; Yousaf, N; Jhanji, S; Tatham, K; Cunningham, D; Van As, N; Young, K; Furness, AJS; Pickering, L; Beale, R; Swanton, C; Gandhi, S; Gamblin, S; Bauer, DLV; Kassiotis, G; Howell, M; Nicholson, E; Walker, S; Larkin, J; Turajlic, S

Turajlic, S (通讯作者),Francis Crick Inst, Canc Dynam Lab, London NW1 1AT, England.;Turajlic, S (通讯作者),Royal Marsden NHS Fdn Trust, Skin Unit, London, England.;Turajlic, S (通讯作者),Royal Marsden NHS Fdn Trust, Renal Unit, London, England.;Turajlic, S (通讯作者),Inst Canc Res, Melanoma & Kidney Canc Team, London, England.

LANCET, 2022; 399 (10328): 905